Dr. Cassandra Taylor, Quality Considerations for Cannabis and Cannabis-Derived Products for Use in Clinical Trials

May 2022

Cassandra Taylor, Ph.D. is a Chemist at U.S. Food and Drug Administration within the Center for Drug Evaluation and Research (CDER) and is a member of the Botanical Review Team (BRT) residing within the Office of Pharmaceutical Quality (OPQ) and serves as an expert resource on all botanical issues. Dr. Taylor received her B.S. in Chemistry from St. Francis University (2005), and her Ph.D. in Analytical Chemistry from the University of Maryland (2014). Dr. Taylor has evaluated over 100 botanical drug submissions across CDER’s clinical divisions, with a focus on cannabis submissions. She serves as a cannabis subject matter expert (SME) for CDER and across FDA, concentrating on the botanical and quality aspects of cannabis. Dr. Taylor is technical lead on the draft FDA guidance for industry titled “Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research.” She leads and coordinates the CDER Cannabis working group and leads many cannabis initiatives within CDER and FDA. Dr. Taylor is an active SME in the FDA cross-agency cannabis working group, Cannabis Products Committee (CPC). She collaborates with colleagues across FDA to help close substantial knowledge gaps about the science, safety, and quality of cannabis and cannabis-derived products.

Previous Webinars

Kevin Boehnke, PHD.

14 November 2024, 1:00PM MST

Thoughtful approaches to chronic pain and cannabis research

Dr. Kevin Boehnke is an Assistant Professor in the Department of Anesthesiology and the Chronic Pain and Fatigue Research Center. Kevin received his doctorate from the University of Michigan School of Public Health in Environmental Health Sciences in 2017. He is also […]

Read More »

Kenneth Frost, PhD.

Wed, Nov. 20, 11:00AM MST

Recognizing diseases of hemp grown in the U.S. Pacific Northwest

Ken Frost is an Associate Professor and Extension Plant Pathologist in the Department of Botany and Plant Pathology at Oregon State University. His research and extension program is located at the Hermiston Agricultural Research and Extension Center in Hermiston, Oregon, […]

Read More »

Joshua Kellogg, PhD.

Wed, Oct. 16, 11:00AM MST

Cannabinoids: From the Plant to the Gut

Dr. Joshua Kellogg is an Assistant Professor at the Pennsylvania State University, where his lab employs transdisciplinary approaches at the interface of analytical chemistry, chemical biology, natural product chemistry, and molecular biology to further human, plant, animal, and environmental health. His team works to […]

Read More »

Godfrey Pearlson, PHD.

10 October 2024, 1:00PM MST

Cannabis and driving: knowns and known unknowns

Dr. Pearlson’s medical training was at the University of Newcastle upon Tyne in England. Following internship he completed a graduate degree in philosophy at Columbia University in New York and was then successively a resident, postdoctoral fellow and faculty member at Johns Hopkins […]

Read More »

Suman Chandra, MPhil, PhD.

18 September 2024, 11:AM MST

Cannabis: An Old Plant with New Horizons, Botany and Biomass Production for the Drug Development

Dr. Chandra earned his M.Phil. degree in Environmental Plant Physiology and his Ph.D. in Plant Physiology from The High Altitude Plant Physiology Research Center, HNB Garhwal University (A Central University), India. From 1992 to 2000, […]

Read More »

Carrie Cuttler, PHD.

12 September 2024, 1:00PM MST

Chronic and Acute Effects of High Potency Cannabis Flower and Concentrates on Cognition

Dr. Carrie Cuttler received her Ph.D. in Psychology at the University of British Columbia (UBC) and subsequently conducted a post-doctoral fellowship in the Department of Psychiatry at UBC. She is currently an Associate Professor and Director of […]

Read More »